Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multi-center, Randomized, Controlled Study to Evaluate the Safety and Efficacy of the OR3O™ Dual Mobility System Versus Conventional Single Bearing Design Total Hip System in Primary Total Hip Arthroplasty (THA) Procedures.

NCT04941729 is registered in ClinicalTrials.gov with Smith & Nephew Medical (Shanghai) Ltd as lead sponsor.

NCT NCT04941729
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04941729 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multi-center, Randomized, Controlled Study to Evaluate the Safety and Efficacy of the OR3O™ Dual Mobility System Versus Conventional Single Bearing Design Total Hip System in Primary Total Hip Arthroplasty (THA) Procedures.
Lead sponsor
Smith & Nephew Medical (Shanghai) Ltd
Phase
Not applicable
Overall status
Terminated
Start date
June 24, 2022
Completion date
November 3, 2023
Enrollment
24 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

avascular necrosis of femoral head, degenerative hip joint disease, femoral neck fractures, hip dislocation, hip fractures, osteoarthritis (oa), rheumatoid arthritis (ra)